Steven Cohen’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-14,842
Closed -$1.11M – 4358
2026
Q2
$1.11M Sell
14,842
-53,384
-78% -$3.84M ﹤0.01% 2772
2026
Q1
$4.86M Buy
+68,226
New +$4.67M 0.01% 1725
2024
Q2
– Sell
-2,100
Closed -$100K – 2261
2024
Q1
$100K Sell
2,100
-1,700
-45% -$76.4K ﹤0.01% 2011
2023
Q4
$179K Buy
+3,800
New +$158K ﹤0.01% 1830
2019
Q2
– Sell
-15,971
Closed -$1.69M – 1470
2019
Q1
$1.69M Sell
15,971
-25,829
-62% -$2.59M 0.01% 720
2018
Q4
$3.5M Buy
+41,800
New +$3.78M 0.02% 625
2017
Q1
– Sell
-27,400
Closed -$1.5M – 912
2016
Q4
$1.5M Buy
+27,400
New +$1.31M 0.01% 586

Other funds holding NGVT

Steven Cohen's NGVT Position: Q3 2026 in Review

Steven Cohen sold out of Ingevity (NGVT) in Q3 2026, closing a stake of 14,842 shares — an estimated $1.11M sold.

Steven Cohen first reported a position in NGVT in Q4 2016 and held it in 7 quarters. The position peaked at $4.86M in Q1 2026. 341 funds tracked by Wall St. Rank hold NGVT as of Q3 2026.

  • Steven Cohen reported no remaining Ingevity position as of Q3 2026 after selling out during the quarter.
  • Steven Cohen sold 14,842 Ingevity shares in Q3 2026, an estimated $1.11M.
  • Steven Cohen first reported a position in Ingevity in Q4 2016 and held it in 7 quarters.
  • Steven Cohen's Ingevity position peaked at $4.86M in Q1 2026.
  • 341 funds tracked by Wall St. Rank held Ingevity as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.